Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-11-27
2007-11-27
Davis, Zinna N. (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S358000, C514S473000, C514S563000, C514S621000, C546S309000, C546S337000, C549S475000, C558S411000, C562S433000, C564S169000
Reexamination Certificate
active
11238732
ABSTRACT:
Inhibitors of HIV reverse transcriptase which are useful for the treatment of HIV infection. Exemplars of the invention are compounds of the formulawherein the substituents are as defined in the following tableR1R2R4R5R8aFCF3MeH—OHFCF3ClH—OHFCF3MeH—O—CH2CO2HClCNClH—OH.
REFERENCES:
patent: 2439820 (2002-09-01), None
patent: WO 01/17982 (2001-03-01), None
patent: 02070470 (2002-09-01), None
patent: 2004050643 (2004-06-01), None
Wyatt et al, Journal of Medicinal Chemistry, vol. 38, pp. 1657-1665, 1995.
Chan, et al; Novel Benzophenones as Non-nucleoside Reverse Transcriptase Inhibitors of HIV-1; Journal of Medicinal Chemistry; 2004; vol. 47; pp. 1175-1182.
International Preliminary Report on Patentability for PCT/CA2005/001480.
Bonneau Pierre
Deroy Patrick
Gagnon Alexandre
O′Meara Jeffrey
Simoneau Bruno
Boehringer Ingelheim International GmbH
Davis Zinna N.
Devlin Mary-Ellen M.
Morris Michael P.
Stempel Alan R.
LandOfFree
Alkynyl compounds as non nucleoside reverse transcriptase... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Alkynyl compounds as non nucleoside reverse transcriptase..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Alkynyl compounds as non nucleoside reverse transcriptase... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3859210